Shows / Lung Cancer Considered
Lung Cancer Considered
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide…
The show, from its episodes
No episode notes yet. Recurring topics, people and starter picks will appear when notes are available.
Typical episode length
39m · median of 425 episodes with a known length
Solo / guest format
Unknown — existing notes name people mentioned, but do not identify hosts or guests.
Recurring topics
No recurring topics established yet.
Recurring people
No recurring people established yet.
Start here
No starter picks yet — no published episodes with audio and a recorded notes hook.
Episodes
Lung Cancer ConsideredLung Cancer Considered -- Immunotherapy Toxicity: Myths & Pearls
Since the first immunotherapy agent for lung cancer was approved in 2015, this class of drugs has captured the imagination and the narrative for the treatment…
Lung Cancer ConsideredLung Cancer Considered: A New Shot at Progress: Amivantamab Goes SubQ
The FDA has approved subcutaneous amivantamab. Join host Dr. Narjust Florez and guests, Dr. Natasha Leighl and Dr. Federico Cappuzzo, as they explore the…
Lung Cancer ConsideredLung Cancer Considered at the ASCO IASLC 2025 North American Conference on Lung Cancer
In this special episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the IASLC | ASCO 2025 North America…
Lung Cancer ConsideredLung Cancer Care in New Zealand
In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with two thoracic oncologists practicing in New Zealand—Dr. Laird Cameron from Auckland…
Lung Cancer ConsideredLCC in Spanish: Mujeres and oncologia toracica – Latinoamerica
As part of IASLC’s Lung Cancer Considered World Language Series, host Dr. Narjust Florez leads a Spanish-language discussion with three leaders in thoracic…
Lung Cancer ConsideredIASLC Lung Cancer Considered: ADCs in EGFR Mutant NSCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with Prof. Li Zhang and Dr. Elaine Shum about recent progress in antibody–drug…
Lung Cancer ConsideredCan I Take That? Integrative Medicine and Lung Cancer
Join Dr. Narjust Florez as she explores complementary and integrative medicine in lung cancer care with leading experts Dr. Ting Bao, Dr. Jun J. Mao, and Dr…
Lung Cancer ConsideredLCC in Spanish: ¿Pulmón Vital: donde la ciencia se encuentra con la medicina tradicional
As part of IASLC’s Lung Cancer Considered world language series, host Dr. Narjust Florez discusses the role of complementary medicine in cancer care in Spanish…
Lung Cancer ConsideredLCC in Georgian: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredThe New Face of Lung Cancer: A Conversation with Two Young Lung Cancer Warriors
In this episode of Lung Cancer Considered, host Dr. Narjust Florez speaks with two remarkable young lung cancer advocates Samantha Murell and Megan Flanagan…
Lung Cancer ConsideredLCC in Hungarian: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredIASLC Lung Cancer Considered: ESMO 2025 Highlights
This episode of Lung Cancer Considered covers highlights from the 2025 ESMO Annual Meeting held October 17th to the 21st in Berlin, Germany. Guests are: Dr…
Lung Cancer ConsideredLung Cancer Considered: • Rising Above: The Lung Cancer Hope Summit
In this episode of Lung Cancer Considered, Dr. Narjust Florez leads a discussion with Ann Fish-Steagall and Amanda Nerstad about the 2025 Lung Cancer Hope…
Lung Cancer ConsideredLCC in Greek: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredFDA Approval: Maintenance Lurbinectedin for SCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of maintenance lurbinectedin plus atezolizumab for extensive…
Lung Cancer ConsideredLCC in Arabic: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredLung Cancer Considered in Dutch: Targeting EGFR NSCLC
As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Lizza Hendriks moderates a discussion in Dutch with Dr. Marthe…
Lung Cancer ConsideredLung Cancer Considered: Targeting EGFR NSCLC
Lung Cancer Considered: Targeting EGFR NSCLC by IASLC
Lung Cancer ConsideredLung Cancer Considered in Japanese---2025 WCLC Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredLCC in Korean: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredIASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy
This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez and…
Lung Cancer ConsideredLCC in Mandarin: WCLC 2025 Highlights with Experts from Taiwan
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredLCC in Portuguese: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredLCC in Spanish: WCLC 2025 Through a Junior Faculty Lens
In this episode, recorded live in Spanish at WCLC 2025, Dr. Diego Carrillo reflects on his experiences as a junior faculty member at WCLC 2025. In conversation…
Lung Cancer ConsideredLCC in Hebrew: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredLive From WCLC 2025: Tuesday Highlights & Meeting Summary
In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the conference. Dr. Susan…
Lung Cancer ConsideredLCC in Spanish: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredLive From WCLC 2025: Monday Highlights
In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr…
Lung Cancer ConsideredLCC in Mandarin: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredLive From WCLC 2025: Sunday Highlights
In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr…
Lung Cancer Considered"I'm in Barcelona, Now What?" — Tips for First-Time WCLC Attendees
In this episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu share tips for first-time attendees of the World Conference on Lung Cancer…
Lung Cancer ConsideredLCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC
LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC by IASLC

Lung Cancer ConsideredLCC in Greek: Virtual Tumor Board - ALK NSCLC
LCC in Greek: Virtual Tumor Board - ALK NSCLC by IASLC
Lung Cancer ConsideredLung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy
Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy by IASLC
Lung Cancer ConsideredLCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer
LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer by IASLC
Lung Cancer ConsideredFDA Approval: Zongertinib for HER2 Mutant NSCLC
FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC
Lung Cancer ConsideredLCC in Arabic: Arab Women's Voices in Thoracic Oncology
As part of IASLC’s ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Asrar AlAhmadi and Dr. Maya…
Lung Cancer ConsideredArtificial Intelligence (AI) and Lung Cancer Treatment Decisions
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC
Lung Cancer ConsideredArtificial Intelligence (AI) and Lung Cancer Treatment Decisions
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC
Lung Cancer ConsideredLCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania
LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania by IASLC

Lung Cancer ConsideredLCC in Japanese: ASCO 2025 Highlights
LCC in Japanese: ASCO 2025 Highlights by IASLC
Lung Cancer ConsideredPreview: IASLC | ASCO 2025 North American Conference on Lung Cancer
On December 5, 2025, we will kick off the IASLC ASCO 2025 North America Conference on Lung Cancer. Guest include Dr. Ramesh Rengan, the Peter Wootton Professor…
Lung Cancer ConsideredFDA Approval: Datopotamab Deruxtecan for EGFR NSCLC
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC
Lung Cancer ConsideredFDA Approval: Sunvozertinib for EGFR Exon 20
FDA Approval: Sunvozertinib for EGFR Exon 20 by IASLC
Lung Cancer ConsideredLCC in Portuguese: Virtual Tumor Board - EGFR NSCLC
LCC in Portuguese: Virtual Tumor Board - EGFR NSCLC by IASLC

Lung Cancer ConsideredVirtual Tumor Board: Resectable EGFR NSCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case with Dr. Chunxia Su and Dr. Collin Blakely. The case…
Lung Cancer ConsideredFDA Approval: Taletrectinib and ROS1 NSCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of taletrectinib, a next-generation ROS1 kinase inhibitor…
Lung Cancer ConsideredIASLC - ASCO 2025 Highlights
ASCO 2025 Highlights Guests: Charu Aggarwal, MD, MPH Leslye M. Heisler Professor of Medicine Section Chief, Thoracic and Head & Neck Cancer Associate Director…
Lung Cancer ConsideredFDA Approval: Telisotuzumab Vedotin and MET-Positive NSCLC
In this episode, we will discuss the FDA approval of telisotuzumab vedotin, an antibody drug conjugate, for NSCLC with high c-MET expression. To help review…
Lung Cancer ConsideredLCC in Korean: Lung Cancer Updates & Future Directions
LCC in Korean: Lung Cancer Updates & Future Directions by IASLC
Lung Cancer ConsideredGlobal Advances and Persistent Disparities in Lung Cancer Treatment
Global Advances and Persistent Disparities in Lung Cancer Treatment by IASLC


Lung Cancer ConsideredWhat You Should Know About RET-Positive NSCLC: Live from TexasLung25
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Mihaela Aldea about…
Lung Cancer ConsideredExcuse me, What? Top Recommendations for Effective Patient Communication: Live from TexasLung25
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Eric Singhi and Dr…
Lung Cancer ConsideredELCC 2025 Highlights: Insights and Review of the Data
Guest: Dr. Corey Langer is the Director of Thoracic Oncology and Professor of Medicine at the Hospital of the University of Pennsylvania
Lung Cancer ConsideredLCC in Italian: Virtual Tumor Board - Resectable NSCLC
LCC in Italian: Virtual Tumor Board - Resectable NSCLC by IASLC